MICHAEL E RYTTING to Bridged Bicyclo Compounds, Heterocyclic
This is a "connection" page, showing publications MICHAEL E RYTTING has written about Bridged Bicyclo Compounds, Heterocyclic.
Connection Strength
0.136
-
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2020 04; 20(4):212-218.
Score: 0.106
-
Venetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma. J Pediatr Hematol Oncol. 2021 Oct 01; 43(7):e991-e996.
Score: 0.030